Qsemble Capital Management, LP Exact Sciences Corp Transaction History
Qsemble Capital Management, LP
- $751 Billion
- Q4 2024
A detailed history of Qsemble Capital Management, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Qsemble Capital Management, LP holds 27,522 shares of EXAS stock, worth $1.36 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
27,522Holding current value
$1.36 Million% of portfolio
0.21%Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
683Shares Held
163MCall Options Held
3.42MPut Options Held
2.34M-
Capital World Investors Los Angeles, CA17.5MShares$865 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$839 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$595 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$595 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$307 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...